MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

30.00 -2.01 (-6.28%)
Streaming Delayed Price Updated: 2:32 PM EST, Dec 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... 
Via Benzinga
News headline image
Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this... 
Via Benzinga
News headline image
Twist Bioscience Creates Custom Whole Exome Target Enrichment Panel for Canine Genomic Research
From Twist Bioscience Corporation
Via Business Wire
News headline image
Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 Omicron (B.1.1.529/BA.1) and Delta (B.1.617.2) Variants
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches 96-Plex Library Prep Kit for Low Pass High Throughput Next-Generation Sequencing
From Twist Bioscience Corporation
Via Business Wire
News headline image
Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic Antibodies Against GPCR Targets
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Omicron (B.1.1.529/BA.1) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Circulating Tumor DNA Reference Controls for Development of Liquid Biopsy Assays
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Participation in SRC-SIA Webinar on the Decadal Plan for Semiconductors
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at Upcoming Virtual Conferences
From Twist Bioscience
Via Business Wire
News headline image
Why Are Twist Bioscience Shares Plunging Today? ↗
Twist Bioscience Corporation (NASDAQ: TWST) reported a 17% Y/Y increase in its Q4 revenues to $37.95 million, beating the Wall Street estimate of $37.02 million, driven... 
Via Benzinga
News headline image
Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities
From Twist Bioscience Corporation
Via Business Wire
News headline image
Earnings Scheduled For November 22, 2021 ↗
Companies Reporting Before The Bell • Cerence (NASDAQ:CRNC) is estimated to report quarterly earnings at $0.56 per share on revenue of $97.92 million. • Avaya... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Nov. 21-Nov. 27): FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week ↗
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the winding down of the reporting... 
Via Talk Markets
News headline image
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week ↗
Biotech stocks showed a lack of direction in the week ending Nov. 19 before finishing modestly higher. Stocks did not have much meaningful catalysts to react to amid the... 
Via Benzinga
News headline image
Earnings Preview For Twist Bioscience ↗
Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Monday, 2021-11-22. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
Twist Bioscience Expands Partnership with Invetx to Include Discovery of Best-in-Class Antibodies to Treat Multiple Diseases in Cats and Dogs
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Named in Inc.’s First Annual Best-Led Companies List
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2021 Fourth Quarter and Full Year Financial Results on Monday, November 22, 2021
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Launches Exome 2.0 for Genomics Research
From Twist Bioscience Corporation
Via Business Wire
News headline image
Week In Review: Hansoh Signs $456 Million Deal For siRNA Products ↗
Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to... 
Via Talk Markets
News headline image
Twist Bioscience and the Broad Institute Create Custom Whole Exome Target Enrichment Panel for Clinical Research
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Appoints Steffen Hellmold as Senior Vice President, Business Development, Data Storage
From Twist Bioscience Corporation
Via Business Wire
News headline image
Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases ↗
Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for rare diseases. The... 
Via Benzinga
News headline image
Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
From Twist Bioscience Corporation
Via Business Wire
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story